Clinical Trial Update: Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating three different doses of OPC-34712 in adults with acute schizophrenia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lurasidone (Latuda) (lurasidone)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Acute Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-10-29